Stay updated with breaking news from Nasdaq Lrmr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) have been given an average rating of “Buy” by the six research firms that are covering the stock, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have issued ratings on the […]
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report)’s stock price dropped 4.8% during mid-day trading on Tuesday . The stock traded as low as $11.76 and last traded at $11.80. Approximately 33,993 shares changed hands during trading, a decline of 95% from the average daily volume of 625,641 shares. The stock had previously closed at […]
Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) rose 7% during trading on Thursday . The stock traded as high as $13.17 and last traded at $12.80. Approximately 263,608 shares traded hands during trading, a decline of 49% from the average daily volume of 520,626 shares. The stock had previously closed at $11.96. […]
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report)’s stock price was up 7% on Thursday . The company traded as high as $13.17 and last traded at $12.80. Approximately 263,608 shares changed hands during trading, a decline of 49% from the average daily volume of 520,626 shares. The stock had previously closed at $11.96. Analyst […]
Larimar Therapeutics (NASDAQ:LRMR – Get Free Report) had its price target upped by equities research analysts at Citigroup from $4.50 to $10.00 in a report released on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Citigroup’s price target would indicate a potential upside of 2.56% from the company’s current price. […]